AU2003233009A1 - A human cell assay to determine effect of sample compounds on col2 enhancer expression - Google Patents

A human cell assay to determine effect of sample compounds on col2 enhancer expression

Info

Publication number
AU2003233009A1
AU2003233009A1 AU2003233009A AU2003233009A AU2003233009A1 AU 2003233009 A1 AU2003233009 A1 AU 2003233009A1 AU 2003233009 A AU2003233009 A AU 2003233009A AU 2003233009 A AU2003233009 A AU 2003233009A AU 2003233009 A1 AU2003233009 A1 AU 2003233009A1
Authority
AU
Australia
Prior art keywords
col2
human cell
cell assay
sample compounds
determine effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003233009A
Other versions
AU2003233009A8 (en
Inventor
Leonard Buckbinder
Jean Frances Schaefer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of AU2003233009A1 publication Critical patent/AU2003233009A1/en
Publication of AU2003233009A8 publication Critical patent/AU2003233009A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003233009A 2002-06-04 2003-05-26 A human cell assay to determine effect of sample compounds on col2 enhancer expression Abandoned AU2003233009A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38615602P 2002-06-04 2002-06-04
US60/386,156 2002-06-04
PCT/IB2003/002256 WO2003102130A2 (en) 2002-06-04 2003-05-26 A human cell assay to determine effect of sample compounds on col2 enhancer expression

Publications (2)

Publication Number Publication Date
AU2003233009A1 true AU2003233009A1 (en) 2003-12-19
AU2003233009A8 AU2003233009A8 (en) 2003-12-19

Family

ID=29712234

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003233009A Abandoned AU2003233009A1 (en) 2002-06-04 2003-05-26 A human cell assay to determine effect of sample compounds on col2 enhancer expression

Country Status (7)

Country Link
EP (1) EP1576098A2 (en)
JP (1) JP2006500915A (en)
AU (1) AU2003233009A1 (en)
BR (1) BR0311594A (en)
CA (1) CA2488006A1 (en)
MX (1) MXPA04012042A (en)
WO (1) WO2003102130A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8791084B2 (en) 2006-10-27 2014-07-29 Robarts Research Institute Inhibition of SOX9 function in the treatment of proteoglycan-associated pathophysiological conditions
KR102084227B1 (en) * 2018-09-05 2020-03-03 (주)루젠에스씨아이 Human transformed chondrocyte cell line mediated drug screening system for cartilage disease remedy

Also Published As

Publication number Publication date
JP2006500915A (en) 2006-01-12
WO2003102130A3 (en) 2006-06-22
EP1576098A2 (en) 2005-09-21
MXPA04012042A (en) 2005-03-07
BR0311594A (en) 2007-04-27
CA2488006A1 (en) 2003-12-11
WO2003102130A2 (en) 2003-12-11
AU2003233009A8 (en) 2003-12-19

Similar Documents

Publication Publication Date Title
AU2003221808A1 (en) Analyte sensor
AU2003210829A1 (en) Battery-powered wristwatch
AU2003251351A1 (en) Detection of disease by analysis of emissions
AU2003287735A1 (en) Non-invasive measurement of analytes
AU2002329877A1 (en) Cross reference to related art
AU2003225551A1 (en) Synthesis of 2h- and 13c- substituted dithianes
AU2003266346A1 (en) Stabillization of organic materials
AU2003254126A1 (en) Pipelined reconfigurable dynamic instruciton set processor
AU2003219945A1 (en) Enumeration method of analyte detection
AU2003205913A1 (en) Materials and methods relating to cancer diagnosis
AU2003242251A1 (en) Kit for assay development and serial analysis
AU2003206882A1 (en) Analysis of vital substances
AU2002368511A1 (en) Goniometric sensor
AU2003284512A1 (en) Analysis instrument
AU2003232983A1 (en) Analysis of a multi-dimensional structure
AU2003290939A1 (en) Replication of biological tiussue
AU2003250858A1 (en) Use of organic compounds
AU2003226401A1 (en) Gelsolin as a prognostic marker of artherosclerotic diseases
AU2003233009A1 (en) A human cell assay to determine effect of sample compounds on col2 enhancer expression
AU2003237451A1 (en) Microbial conversion of glucose to para-hydroxystyrene
AU2003222371A1 (en) Use of a capacitive probe to determine the biomass of small bacteria
AU2003234210A1 (en) Direct cell target analysis
AU2003240448A1 (en) Detection of mycobacteria in clinical material
AUPS239302A0 (en) Improvements to tow-bars
AU2003222988A1 (en) Improvements relating to signal enhancement

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase